Nova Patents
AT233102T

Method and composition for reconforming multi-epitopic antigens to initiate an immune response

Abstract

The present invention is concerned with the initiation of a fusion reaction and / or the capillary processes and compositions. Specifically, using the inventive methods and compositions, the immunity of multipath epitopes can be resolved in the form of a specific binding agent, exclusively an epitope-binding specific antigen, whose binding to the antigen's agonizing properties. ŕ

Term

No projected expiry on record.

  1. Priority and filed
  2. Granted
  3. Today

105 members in 22 offices

This recordMember, by publication datePriority claim12 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
9600461International Bureau of the World Intellectual Property Organization (WIPO)W

Members105

Family members, oldest first
DocumentOfficeKind
CA2253602A1CanadaA1
WO9742973A1World Intellectual Property Organization (WIPO)A1
AU5658096AAustraliaA
WO9802762A2World Intellectual Property Organization (WIPO)A2
AU4643997AAustraliaA
WO9802762A3World Intellectual Property Organization (WIPO)A3
NO20061203LNorwayL
NO985304D0NorwayD0
NO985304LNorwayL
CA2292912A1CanadaA1
WO9857661A1World Intellectual Property Organization (WIPO)A1
AU8143998AAustraliaA
EP0908022A2European Patent Office (EPO)A2
EP0910407A1European Patent Office (EPO)A1
BR9612619ABrazilA
IL126803D0IsraelD0
JPH11509558AJapanA
AU711270B2AustraliaB2
CN1238868AChinaA
CA2333221A1CanadaA1
WO9965517A2World Intellectual Property Organization (WIPO)A2
AU4159399AAustraliaA
WO9965517A3World Intellectual Property Organization (WIPO)A3
CA2253058A1CanadaA1
HU9903770A2HungaryA2
HUP9903770A2HungaryA2
ZA9810275BSouth AfricaB
EP1009433A1European Patent Office (EPO)A1
US6086873AUnited States of AmericaA
NZ332588ANew ZealandA
EP1085902A2European Patent Office (EPO)A2
AU732505B2AustraliaB2
US6241985B1United States of AmericaB1
HU9903770A3HungaryA3
HUP9903770A3HungaryA3
CA2399067A1CanadaA1
WO0159452A2World Intellectual Property Organization (WIPO)A2
AU4098201AAustraliaA
US2001036457A1United States of AmericaA1
NZ503032ANew ZealandA
JP2002504154AJapanA
KR20020011137ARepublic of KoreaA
IL139832D0IsraelD0
US2002022235A1United States of AmericaA1
NZ505174ANew ZealandA
US2002048586A1United States of AmericaA1
NZ516264ANew ZealandA
JP2002518342AJapanA
WO0159452A3World Intellectual Property Organization (WIPO)A3
EP1254374A2European Patent Office (EPO)A2
EP0910407B1European Patent Office (EPO)B1
AT233102TThis recordAustriaT
ATE233102T1AustriaT1
EP1297846A1European Patent Office (EPO)A1
DE69626423D1GermanyD1
CA2464947A1CanadaA1
WO03034977A2World Intellectual Property Organization (WIPO)A2
DK0910407T3DenmarkT3
AU762699B2AustraliaB2
JP2003522774AJapanA
PT910407EPortugalE
SI0910407T1SloveniaT1
ES2193240T3SpainT3
IL126803AIsraelA
DE69626423T2GermanyT2
NO20042166LNorwayL
GB0409191D0United KingdomD0
WO03034977A3World Intellectual Property Organization (WIPO)A3
GB2397018AUnited KingdomA
JP3565351B2JapanB2
DE10297379T5GermanyT5
EP1009433A4European Patent Office (EPO)A4
US2005063976A1United States of AmericaA1
AT500649A1AustriaA1
AU2001240982B2AustraliaB2
NO321511B1NorwayB1
GB2397018BUnited KingdomB
US2006159688A1United States of AmericaA1
IL139832AIsraelA
US2007036798A1United States of AmericaA1
EP1254374B1European Patent Office (EPO)B1
US2007092522A1United States of AmericaA1
AT360212TAustriaT
ATE360212T1AustriaT1
DE60127935D1GermanyD1
PT1254374EPortugalE
EP1820514A2European Patent Office (EPO)A2
EP1821104A2European Patent Office (EPO)A2
DK1254374T3DenmarkT3
EP1820514A3European Patent Office (EPO)A3
EP1821104A3European Patent Office (EPO)A3
ES2284624T3SpainT3
CH696871A5SwitzerlandA5
US7318921B2United States of AmericaB2
DE60127935T2GermanyT2
AU2002358246B2AustraliaB2
US7361346B1United States of AmericaB1
US2008131443A1United States of AmericaA1
US2008206318A1United States of AmericaA1
US2008220012A1United States of AmericaA1
Showing 100 of 105